Trust your instincts, if something feels wrong, it's always best to check with your health care provider
The search for alternative therapies is vital, especially for women who cannot or prefer not to use hormone replacement therapy due to potential risks or side effects
Trial data shows robust response across this group, with 91.7% achieving at least 10% weight loss
More work in traumatic brain injury models has examined T4s capacity to promote neurogenesis, reduce lesion volume, and improve behavioral outcomes in rodents
The most prevalent factors employers are taking into consideration for GLP-1 drug coverage for obesity care include: 76%Obesity as a risk factor for chronic conditions and associated costs 71%Broker/consultant/PBM recommendations 62%Impact/effectiveness of cost-control mechanisms 57%GLP-1 label expansion 56%Long-term costs 39%Lack of clinical studies for long-term use of GLP-1 drugs
Per KFF 2025, 43% of firms with 5,000-plus employees cover weight-loss GLP-1s (up from 28%), but only 30% of firms with 1,000 to 4,999 employees and 16% of firms with 200 to 999